fda warning letters compounded semaglutide september 2025 Congress Introduces SAFE Drugs Act of 2025, Expanding Oversight of GLP-1 Drugs and Telehealth Providers FDA unleashes warning letters to

The Regenesis Complex uses peptide-based ingredients to support skin structure and smoothness

This article reviews the emerging trend of microdosing GLP-1 drugs, examining potential benefits, risks, and the current lack of scientific evidence supporting this approach

Patients who are considering starting on one of the newest weight loss drugs will want to think carefully before starting on the medications, doctors said

Insurance companies need to determine coverage

10.1152/ajpendo.00600.2012 124

Glycine, a conditionally essential amino acid, activates mTORC1 signaling pathways that protect lean muscle tissue during caloric restriction